Huimei Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Huimei Zheng has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Xiaohang Yang
Institute of Genetics, Zhejiang University International School of Medicine, Hangzhou, China
4 shared publications - Yongmei Xi
Institute of Genetics, Zhejiang University International School of Medicine, 310058 Hangzhou, Zhejiang, China
3 shared publications Jia Wang
Center for Genetic Medicine, Zhejiang University International Institute of Medicine
2 shared publications- Jingping Li
Department of Reproductive Endocrinology, the Women's Hospital, Zhejiang University School of Medicine, China
2 shared publications Yongmei Xi
Zhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, the Women's Hospital, Zhejiang University School of Medicine
2 shared publicationsYunbo Wang
Center for Genetic Medicine, Zhejiang University International Institute of Medicine
2 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1916743
A homozygous SPDYA variant associated with meiotic arrest and failed microdissection testicular sperm extraction in non-obstructive azoospermia
Background: Non-obstructive azoospermia (NOA) with meiotic maturation arrest is a severe form of male infertility for which genetic diagnosis may inform counseling and sperm-retrieval expectations. Methods: Whole-exome sequencing was performed in a consanguineous family with NOA, followed by SPDYA variant screening in 31 unrelated NOA patients and 469 men with documented reproductive outcomes. The proband underwent clinical evaluation and microdissection testicular sperm extraction (micro-TESE). Testicular histology, immunofluorescence staining, and meiotic chromosome-spread analysis were used to assess spermatogenic progression. Structural modeling, immunoblotting, co-immunoprecipitation, and exploratory bulk RNA sequencing were performed using testicular material from the proband and a pooled obstructive azoospermia control reference. The three libraries per condition were technical library replicates, not independent biological replicates. Results: A homozygous SPDYA missense variant (NM_182756.4:c.596G>A; p.R199H) was identified in the proband, and both parents were heterozygous carriers. No additional biallelic deleterious SPDYA variants were detected in the screening cohort. The patient showed NOA, reduced testicular volume, spermatocyte-stage maturation arrest, and failed micro-TESE. Cytological analyses showed absence of post-meiotic germ cells, persistent nuclear γH2AX, failed XY body formation, and no pachytene or diplotene spermatocytes. Structural modeling and co-immunoprecipitation were compatible with weakened SPDYA-CDK2 association, and immunoblotting showed lower apparent abundance of SPDYA, CDK2, and SUN1 in the patient sample. Exploratory transcriptomic profiling showed fold-change-based tissue-level trends consistent with early meiotic arrest and loss of post-meiotic germ-cell programs, rather than direct transcriptional effects of the variant. Conclusion: This single case suggests that biallelic SPDYA variants may be associated with poor sperm retrieval outcomes in severe meiotic arrest, but larger multicenter cohorts are strictly required before SPDYA can be used for clinical prediction or surgical decision-making.
- 7 September 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1916743
Open AccessA homozygous SPDYA variant associated with meiotic arrest and failed microdissection testicular sperm extraction in non-obstructive azoospermia
Background: Non-obstructive azoospermia (NOA) with meiotic maturation arrest is a severe form of male infertility for which genetic diagnosis may inform counseling and sperm-retrieval expectations. Methods: Whole-exome sequencing was performed in a consanguineous family with NOA, followed by SPDYA variant screening in 31 unrelated NOA patients and 469 men with documented reproductive outcomes. The proband underwent clinical evaluation and microdissection testicular sperm extraction (micro-TESE). Testicular histology, immunofluorescence staining, and meiotic chromosome-spread analysis were used to assess spermatogenic progression. Structural modeling, immunoblotting, co-immunoprecipitation, and exploratory bulk RNA sequencing were performed using testicular material from the proband and a pooled obstructive azoospermia control reference. The three libraries per condition were technical library replicates, not independent biological replicates. Results: A homozygous SPDYA missense variant (NM_182756.4:c.596G>A; p.R199H) was identified in the proband, and both parents were heterozygous carriers. No additional biallelic deleterious SPDYA variants were detected in the screening cohort. The patient showed NOA, reduced testicular volume, spermatocyte-stage maturation arrest, and failed micro-TESE. Cytological analyses showed absence of post-meiotic germ cells, persistent nuclear γH2AX, failed XY body formation, and no pachytene or diplotene spermatocytes. Structural modeling and co-immunoprecipitation were compatible with weakened SPDYA-CDK2 association, and immunoblotting showed lower apparent abundance of SPDYA, CDK2, and SUN1 in the patient sample. Exploratory transcriptomic profiling showed fold-change-based tissue-level trends consistent with early meiotic arrest and loss of post-meiotic germ-cell programs, rather than direct transcriptional effects of the variant. Conclusion: This single case suggests that biallelic SPDYA variants may be associated with poor sperm retrieval outcomes in severe meiotic arrest, but larger multicenter cohorts are strictly required before SPDYA can be used for clinical prediction or surgical decision-making.
- Open Access
- 22 October 2025
- Published by Springer Nature in Cell & Bioscience
- Vol. 15 (1) , 1-18
Ssrp governs germline development independent of the FACT complex in Drosophila spermatogenesis
The heterodimeric FACT complex (SSRP1/Ssrp and SUPT16H/Dre4) is primarily recognized as a chromatin remodeler. While mutations in this complex are linked to human intellectual disability and it maintains neural stem cell fate in flies, single-cell RNA sequencing reveals robust FACT complex expression in human testicular germ cells. Nevertheless, its specific functions during spermatogenesis remain unexplored. This study utilized Drosophila melanogaster as a model to investigate the roles of FACT complex during spermatogenesis. Germline-specific and somatic-specific knockdowns of Ssrp and dre4 combined with immunostaining were performed to assess their functions. Bulk and single-cell RNA sequencing analyses were conducted on Ssrp-deficient testes to investigate transcriptomic changes. Our study uncovers context-dependent functions for Ssrp. In testis somatic cells, Ssrp collaborates with Dre4 to sustain cyst stem cell populations via estrogen-related receptor-mediated glycolytic activation. Remarkably, germline Ssrp operates independently of Dre4, governing transit-amplifying divisions and meiotic progression. Germline-specific Ssrp depletion, but not dre4 knockdown, induces male sterility, characterized by spermatogonial accumulation, mitotic asynchrony, and meiotic arrest within primary spermatocytes. Bulk and single-cell RNA sequencing analyses of Ssrp-deficient testes reveal systemic transcriptomic dysregulation, including suppression of metabolic programs (glycolysis and oxidative phosphorylation) and activation of MAPK/EGFR signaling. Ssrp loss disrupts sister centromere cohesion during meiosis I, as well as diminished ATP levels and aberrant CENP-A accumulation, suggesting a dual regulatory nexus linking energy metabolism to chromosomal stability. This work reveals previously unknown, context-dependent functions of Ssrp during Drosophila spermatogenesis. Ssrp emerges as a multifunctional orchestrator essential for both somatic and germline compartments of germline development. These findings provide crucial foundational insights into reproductive disorders associated with Ssrp dysfunction and underscore the importance of the FACT complex in male germ cell development.
- 22 October 2025
- Published by Springer Nature in Cell & Bioscience
- Vol. 15 (1) , 1-18
Open AccessSsrp governs germline development independent of the FACT complex in Drosophila spermatogenesis
The heterodimeric FACT complex (SSRP1/Ssrp and SUPT16H/Dre4) is primarily recognized as a chromatin remodeler. While mutations in this complex are linked to human intellectual disability and it maintains neural stem cell fate in flies, single-cell RNA sequencing reveals robust FACT complex expression in human testicular germ cells. Nevertheless, its specific functions during spermatogenesis remain unexplored. This study utilized Drosophila melanogaster as a model to investigate the roles of FACT complex during spermatogenesis. Germline-specific and somatic-specific knockdowns of Ssrp and dre4 combined with immunostaining were performed to assess their functions. Bulk and single-cell RNA sequencing analyses were conducted on Ssrp-deficient testes to investigate transcriptomic changes. Our study uncovers context-dependent functions for Ssrp. In testis somatic cells, Ssrp collaborates with Dre4 to sustain cyst stem cell populations via estrogen-related receptor-mediated glycolytic activation. Remarkably, germline Ssrp operates independently of Dre4, governing transit-amplifying divisions and meiotic progression. Germline-specific Ssrp depletion, but not dre4 knockdown, induces male sterility, characterized by spermatogonial accumulation, mitotic asynchrony, and meiotic arrest within primary spermatocytes. Bulk and single-cell RNA sequencing analyses of Ssrp-deficient testes reveal systemic transcriptomic dysregulation, including suppression of metabolic programs (glycolysis and oxidative phosphorylation) and activation of MAPK/EGFR signaling. Ssrp loss disrupts sister centromere cohesion during meiosis I, as well as diminished ATP levels and aberrant CENP-A accumulation, suggesting a dual regulatory nexus linking energy metabolism to chromosomal stability. This work reveals previously unknown, context-dependent functions of Ssrp during Drosophila spermatogenesis. Ssrp emerges as a multifunctional orchestrator essential for both somatic and germline compartments of germline development. These findings provide crucial foundational insights into reproductive disorders associated with Ssrp dysfunction and underscore the importance of the FACT complex in male germ cell development.
- Open Access
- 16 October 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (20)
X-linked RBBP7 mutation causes maturation arrest and testicular tumors
Maturation arrest (MA) is a subtype of non-obstructive azoospermia, and male infertility is a known risk factor for testicular tumors. However, the genetic basis for many affected individuals remains unknown. Here, we identified a deleterious hemizygous variant of X-linked retinoblastoma-binding protein 7 (RBBP7) as a potential key cause of MA, which was also found to be associated with the development of Leydig cell tumors. This mutation resulted in premature protein translation termination, affecting the sixth WD40 domain of the RBBP7 and the interaction of the mutated RBBP7 with histone H4. Decreased BRCA1 and increased γH2AX were observed in the proband. In mouse spermatogonial and pachytene spermatocyte-derived cells, deprivation of rbbp7 led to cell cycle arrest and apoptosis. In Drosophila, knockdown of RBBP7/Caf1-55 in germ cells resulted in complete absence of germ cells and reduced testis size, whereas knockdown of RBBP7/Caf1-55 in cyst cells resulted in hyperproliferative testicular cells. Interestingly, male infertility caused by Caf1-55 deficiency was rescued by ectopic expression of wild-type human RBBP7 but not mutant variants, suggesting the importance of RBBP7 in spermatogenesis. Our study provides insights into the mechanisms underlying the co-occurrence of MA and testicular tumors and may pave the way for innovative genetic diagnostics of these 2 diseases.
- 16 October 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (20)
Open AccessX-linked RBBP7 mutation causes maturation arrest and testicular tumors
Maturation arrest (MA) is a subtype of non-obstructive azoospermia, and male infertility is a known risk factor for testicular tumors. However, the genetic basis for many affected individuals remains unknown. Here, we identified a deleterious hemizygous variant of X-linked retinoblastoma-binding protein 7 (RBBP7) as a potential key cause of MA, which was also found to be associated with the development of Leydig cell tumors. This mutation resulted in premature protein translation termination, affecting the sixth WD40 domain of the RBBP7 and the interaction of the mutated RBBP7 with histone H4. Decreased BRCA1 and increased γH2AX were observed in the proband. In mouse spermatogonial and pachytene spermatocyte-derived cells, deprivation of rbbp7 led to cell cycle arrest and apoptosis. In Drosophila, knockdown of RBBP7/Caf1-55 in germ cells resulted in complete absence of germ cells and reduced testis size, whereas knockdown of RBBP7/Caf1-55 in cyst cells resulted in hyperproliferative testicular cells. Interestingly, male infertility caused by Caf1-55 deficiency was rescued by ectopic expression of wild-type human RBBP7 but not mutant variants, suggesting the importance of RBBP7 in spermatogenesis. Our study provides insights into the mechanisms underlying the co-occurrence of MA and testicular tumors and may pave the way for innovative genetic diagnostics of these 2 diseases.
- Open Access
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Lipidomic Alterations and PPARα Activation Induced by Resveratrol Lead to Reduction in Lesion Size in Endometriosis Models
Endometriosis is an estrogen‐dependent chronic inflammatory disease that affects approximately 10% of women of reproductive age and up to 50% of women with infertility. The heterogeneity of the disease makes accurate diagnosis and treatment a clinical challenge. In this study, we generated two models of endometriosis: the first in rats and the second using human ectopic endometrial stromal cells (HEcESCs) derived from the lesion tissues of endometriosis patients. We then applied resveratrol to assess its therapeutic potential. Resveratrol intervention had significant efficacy to attenuate lesion size and to rectify aberrant lipid profiles of model rats. Lipidomic analysis revealed significant lipidomic alterations, including notable increases of sphingolipids and decreases of both glycerolipids and most phospholipids. Upon resveratrol application, both proliferation capacity and invasiveness parameters decreased, and the early apoptosis proportion increased for HEcESCs. The activation of PPARα was also noted as a factor potentially contributing to recovery from endometriosis in both models. Our study provides valuable insight into the mechanisms of resveratrol in endometriosis and therefore strengthens the potential for optimizing resveratrol treatment for this disease.
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Open AccessLipidomic Alterations and PPARα Activation Induced by Resveratrol Lead to Reduction in Lesion Size in Endometriosis Models
Endometriosis is an estrogen‐dependent chronic inflammatory disease that affects approximately 10% of women of reproductive age and up to 50% of women with infertility. The heterogeneity of the disease makes accurate diagnosis and treatment a clinical challenge. In this study, we generated two models of endometriosis: the first in rats and the second using human ectopic endometrial stromal cells (HEcESCs) derived from the lesion tissues of endometriosis patients. We then applied resveratrol to assess its therapeutic potential. Resveratrol intervention had significant efficacy to attenuate lesion size and to rectify aberrant lipid profiles of model rats. Lipidomic analysis revealed significant lipidomic alterations, including notable increases of sphingolipids and decreases of both glycerolipids and most phospholipids. Upon resveratrol application, both proliferation capacity and invasiveness parameters decreased, and the early apoptosis proportion increased for HEcESCs. The activation of PPARα was also noted as a factor potentially contributing to recovery from endometriosis in both models. Our study provides valuable insight into the mechanisms of resveratrol in endometriosis and therefore strengthens the potential for optimizing resveratrol treatment for this disease.
- Open Access
PRL-1 is required for neuroprotection against olfactory CO 2 stimulation in Drosophila
The Mammalian phosphatase of regenerating liver (PRL) family is primarily recognized for its oncogenic properties. Here we found that in Drosophila, loss of prl-1 resulted in CO2-induced brain disorder presented as irreversible wing hold up with enhancement of Ca2+ responses at the neuron synaptic terminals. Overexpression of Prl-1 in the nervous system could rescue the mutant phenotype. We show that Prl-1 is particularly expressed in CO2-responsive neural circuit and the higher brain centers. Ablation of the CO2 olfactory receptor, Gr21a, suppressed the mutant phenotype, suggesting that CO2 acts as a neuropathological substrate in absence of Prl-1. Further studies found that the wing hold up is an obvious consequence upon knockdown of Uex, a magnesium transporter, which directly interacts with Prl-1. Conditional expression of Uex in the nervous system could rescue the phenotype of prl-1 mutants. We demonstrate that Uex acts genetically downstream of Prl-1. Our findings provide important insights into mechanisms of Prl-1 protection against olfactory CO2 stimulation induced brain disorder at the level of detailed neural circuits and functional molecular connections.
Open AccessPRL-1 is required for neuroprotection against olfactory CO 2 stimulation in Drosophila
The Mammalian phosphatase of regenerating liver (PRL) family is primarily recognized for its oncogenic properties. Here we found that in Drosophila, loss of prl-1 resulted in CO2-induced brain disorder presented as irreversible wing hold up with enhancement of Ca2+ responses at the neuron synaptic terminals. Overexpression of Prl-1 in the nervous system could rescue the mutant phenotype. We show that Prl-1 is particularly expressed in CO2-responsive neural circuit and the higher brain centers. Ablation of the CO2 olfactory receptor, Gr21a, suppressed the mutant phenotype, suggesting that CO2 acts as a neuropathological substrate in absence of Prl-1. Further studies found that the wing hold up is an obvious consequence upon knockdown of Uex, a magnesium transporter, which directly interacts with Prl-1. Conditional expression of Uex in the nervous system could rescue the phenotype of prl-1 mutants. We demonstrate that Uex acts genetically downstream of Prl-1. Our findings provide important insights into mechanisms of Prl-1 protection against olfactory CO2 stimulation induced brain disorder at the level of detailed neural circuits and functional molecular connections.